Clinical research development has long been targeted as an area of opportunity for pharmaceutical companies and investigator sites to find more efficient methods of adoption to drive success in commercializing a product. Friend of Vynamic, Amy Nordo joins us on this episode as we dive into the topic of Clinical Trials and how innovation is making its way into this critical function between a pharmaceutical company and the provider settings.
Resources
Mindy discussed an article published by Kaiser Health News entitled “Death By 1,000 Clicks: Where Electronic Records Went Wrong.” The article provides an evaluation on the growth of the EHR industry as part of the Digital Revolution.
https://khn.org/news/death-by-a-thousand-clicks/
Ryan discussed the news coming from the Cleveland Clinic of the first baby in North America delivered by a mother who received a uterus transplant from a deceased donor.
9 October 2019
19 July 2019
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, New York, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Felice Walter
Life science organizations often encounter challenges with aligning strategy and execution during a product launch, leading to inefficiencies...
Read more
Felice Walter
In today's competitive pharmaceutical environment, the success of product launches hinges on the ability to prioritize outcomes over rigid processes..
Read moreLast month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s...
Listen now